Can strawberries mitigate Alzheimer’s risk? Recent study suggests a possibility

Whether strawberry supplementation mitigates the risk for late-life dementia.

PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine) – Psychedelic Alpha

FDA assigns GDUFA goal date of April 29, 2024 Milestone builds upon PharmaTher’s commitment toward unlocking the potential of ketamine for unmet medical needs TORONTO,

September 27, 2023

GM-2505 by Gilgamesh Pharmaceuticals for Psychiatric Disorders: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 5, 2023

Wastewater study sheds light on tracking cannabis use challenges

Researchers explore wastewater-based surveillance (WBS) as a tool to monitor cannabis use, identifying analytical challenges and the need for more precise methodologies.

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.